U.S. FDA panel backs approval of Paratek's antibiotic - Bio-Defense Network
Aug 2018

U.S. FDA panel backs approval of Paratek’s antibiotic

A U.S. Food and Drug Administration expert panel on Wednesday voted in favor of approval of Paratek Pharmaceuticals Inc’s antibiotic to treat bacterial pneumonia and skin infections.

The panel voted 17-1 in favor of the drug’s safety and effectiveness in treating acute bacterial skin and skin structure infections, and voted 14-4 for treating community acquired bacterial pneumonia.



Leave a Reply

Your email address will not be published. Required fields are marked *